When you think of arthritis, achy, warm, swollen joints probably come to mind. These are indeed some of the most common symptoms of arthritis. But did you know there are actually over 100 different ...

NEW YORK CITY — Urate, the culprit of gout, affects the vasculature in multiple ways that can raise cardiovascular risk (CV) in an individual with gout, and following guidelines for gout treatment, ...

The study revealed how a second drug taken orally more than doubled the effectiveness of Pegloticase, an intravenous gout treatment used to dissolve crystalized uric acid in the joints when oral ...

“The acquisition of Arthrosi allows us to expand our gout pipeline with a highly differentiated new asset. Pozdeutinurad has the potential to become the therapy of choice for patients who have ...

Sobi, which currently has a drug under FDA review as a later line of therapy for gout, is paying $950 million to acquire ...

Gout is an intensely painful form of arthritis that affects over 8 million Americans. As our diets change to include more processed foods, and with the increase in popularity of high protein diets, ...

The burden of cardiovascular-kidney-metabolic (CKM) comorbidities among adults with gout is high, noted Chio Yokose, MD, MSc, of Massachusetts General Hospital in Boston, at the American College of ...

Gout is a painful form of arthritis that affects the joints. Flare-ups often target the joint of the big toe. Gout is caused by a buildup of too much uric acid in your body. The excess uric acid ...

Xanthine oxidase inhibitors, primarily allopurinol and febuxostat, are the mainstay of treatment. The goal of chronic gout management includes lowering serum urate levels to below 6 mg/dL. 5 Overall, ...

Per the terms of the agreement, Sobi is expected to pay upwards of $950 million upfront in cash to acquire Arthrosi.The deal also includes up to $550 million in cash in clinical, regulatory, and sales ...

Gout is a growing threat to the world population. Moreover, the prevalence of comorbidities is higher in gout patients. Study: Urate-Lowering Therapy Use among US Adults with Gout and the Relationship ...